Does XTANDI Cause Decreased appetite? 56 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Decreased appetite have been filed in association with XTANDI. This represents 4.0% of all adverse event reports for XTANDI.
56
Reports of Decreased appetite with XTANDI
4.0%
of all XTANDI reports
12
Deaths
8
Hospitalizations
How Dangerous Is Decreased appetite From XTANDI?
Of the 56 reports, 12 (21.4%) resulted in death, 8 (14.3%) required hospitalization, and 1 (1.8%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XTANDI. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does XTANDI Cause?
Malignant neoplasm progression (235)
Death (234)
Fatigue (162)
Drug ineffective (158)
Prostatic specific antigen increased (94)
Nausea (69)
Asthenia (62)
Dizziness (52)
Diarrhoea (51)
Back pain (41)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)